{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:05:25Z","timestamp":1761807925360},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ejso.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T02:18:11Z","timestamp":1425435491000},"page":"653-658","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Review of anal cancer patients at the Ottawa hospital"],"prefix":"10.1016","volume":"41","author":[{"given":"M.","family":"Abunassar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Reinders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Asmis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2015.02.004_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejso.2015.02.004_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2015.02.004_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00002030-199403000-00001","article-title":"Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem","volume":"8","author":"Palefsky","year":"1994","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.ejso.2015.02.004_bib4","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.02.004_bib5","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.02.004_bib6","series-title":"American Joint Committee on Cancer Staging manual","first-page":"165","year":"2010"},{"key":"10.1016\/j.ejso.2015.02.004_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/1097-0142(19810715)48:2<411::AID-CNCR2820480232>3.0.CO;2-Z","article-title":"Malignant epithelial tumors of the anal canal","volume":"48","author":"Singh","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2015.02.004_bib8","first-page":"729","article-title":"Management of carcinoma of anal canal","volume":"90","author":"Schneider","year":"1981","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2015.02.004_bib9","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/1097-0142(19830401)51:7<1291::AID-CNCR2820510719>3.0.CO;2-R","article-title":"Depth of invasion, location, and size of cancer of the anus dictate operative treatment","volume":"51","author":"Schraut","year":"1983","journal-title":"Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.ejso.2015.02.004_bib10","doi-asserted-by":"crossref","first-page":"v87","DOI":"10.1093\/annonc\/mdq171","article-title":"Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Glynne-Jones","year":"2010","journal-title":"Ann Oncol"},{"issue":"35","key":"10.1016\/j.ejso.2015.02.004_bib11","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2015.02.004_bib12","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.1996.14.12.3121","article-title":"Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients","author":"Doci","year":"1996","journal-title":"JCO"},{"issue":"6","key":"10.1016\/j.ejso.2015.02.004_bib13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00a0\u00d7\u00a02 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2015.02.004_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DCR.0000000000000057","article-title":"Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease","volume":"57","author":"Fraunholz","year":"2014","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"10.1016\/j.ejso.2015.02.004_bib15","first-page":"6","article-title":"Costly HPV vaccination still a tough sell","volume":"44","author":"Hodges","year":"2008","journal-title":"Med Post"},{"issue":"1","key":"10.1016\/j.ejso.2015.02.004_bib16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1471-2407-10-189","article-title":"Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas","volume":"10","author":"Van Damme","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2015.02.004_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/apm.12306","article-title":"KRAS and BRAF mutations in anal carcinoma","volume":"123","author":"Serup-Hansen","year":"2014","journal-title":"APMIS"},{"issue":"5","key":"10.1016\/j.ejso.2015.02.004_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"issue":"17","key":"10.1016\/j.ejso.2015.02.004_bib19","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2013.52.3464","article-title":"Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal","volume":"32","author":"Serup-Hansen","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2015.02.004_bib20","first-page":"443","article-title":"Prognostic significance of Cyclin A in epidermoid anal cancer","volume":"16","author":"Nilsson","year":"2006","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.ejso.2015.02.004_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2559.2001.01161.x","article-title":"Reduced expression of p21WAF1 is an indicator of malignant behaviour in anal carcinomas","volume":"39","author":"Holm","year":"2001","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.ejso.2015.02.004_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.bjc.6602111","article-title":"Cyclin D1, cyclin E, and p21 have no apparent prognostic value in anal carcinomas treated by radiotherapy with or without chemotherapy","volume":"91","author":"Allal","year":"2004","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2015.02.004_bib23","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2559.2009.03364.x","article-title":"YKL-40 expression in anal carcinoma predicts shorter overall and disease-free survival","volume":"55","author":"Castellano","year":"2009","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.ejso.2015.02.004_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1007\/s10620-009-0812-6","article-title":"Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation","volume":"55","author":"Ajani","year":"2010","journal-title":"Dig Dis Sci"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798315000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T12:37:20Z","timestamp":1566391040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798315000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0748798315000773"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2015.02.004","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of anal cancer patients at the Ottawa hospital","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}